Blueprint Medicines Corp
BPMCDelisted Jul 18, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001597264
Blueprint Medicines Corp was delisted on Jul 18, 2025; its insiders filed their last Form 4 on Jul 21, 2025; 356 institutions reported holding it in 13F filings for Q2 2025, worth $8.65B in total; Soros Fund Management was the only superinvestor holding it.
Q2 2026 vs. Q1 2026
How the institutions holding Blueprint Medicines Corp changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 6 | 4 | −2 |
| Shares | 326 | 282 | −44 (−13.5%) |
| Value | $38.6K | $129 | −$38.5K (−99.7%) |
New holders (1)
Institutions that held Blueprint Medicines Corp at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| GAMMA Investing LLC | 271 | $0 | 0.00% |
Sold out (3)
Institutions that held Blueprint Medicines Corp at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Wall Street Access Asset Management, LLC | 300 | $38.5K |
| Golden State Equity Partners | 11 | $0 |
| Keating Financial Advisory Services, Inc. | 4 | $0 |